“Twin peaks”: Searching for 4-hydroxynonenal urinary metabolites after oral administration in rats
Open Access
- 1 April 2015
- journal article
- Published by Elsevier in Redox Biology
- Vol. 4, 136-148
Abstract
No abstract availableKeywords
Funding Information
- COST (CM1001)
This publication has 30 references indexed in Scilit:
- 4-Hydroxy-2(E)-nonenal Metabolism Differs in Apc+/+ Cells and in ApcMin/+ Cells: It May Explain Colon Cancer Promotion by Heme IronChemical Research in Toxicology, 2011
- Hepatotoxicity and Nephrotoxicity Produced by 4-Hydroxy-2-Nonenal (4-HNE) Following 4-Week Oral Administration to Sprague-Dawley RatsJournal of Toxicology and Environmental Health, Part A, 2011
- Luminal sulfide and large intestine mucosa: friend or foe?Amino Acids, 2009
- 4-Hydroxy-2-alkenals in polyunsaturated fatty acids-fortified infant formulas and other commercial food productsFood Additives & Contaminants, 2007
- New Marker of Colon Cancer Risk Associated with Heme Intake: 1,4-Dihydroxynonane Mercapturic AcidCancer Epidemiology, Biomarkers & Prevention, 2006
- Apc mutation induces resistance of colonic cells to lipoperoxide-triggered apoptosis induced by faecal water from haem-fed ratsCarcinogenesis, 2006
- Antioxidative Function and Substrate Specificity of NAD(P)H- dependent Alkenal/one OxidoreductaseJournal of Biological Chemistry, 2001
- Identification of Novel Urinary Metabolites of the Lipid Peroxidation Product 4-Hydroxy-2-nonenal in RatsChemical Research in Toxicology, 1998
- Disposition in rat of [2-3H]-trans-4-hydroxy-2,3-nonenal, a product of lipid peroxidationXenobiotica, 1996
- Trans -4-Hydroxy-2-Hexenal: a Reactive Metabolite from the Macrocyclic Pyrrolizidine Alkaloid SenecionineScience, 1985